Abstract:Introduction Dilated cardiomyopathy (DCM) exhibits an annual incidence of 5-7 cases per 100,000 persons and a worldwide prevalence of 1:2500 individuals, with a genetic involvement in 35% of all cases (TTN and LMNA gene mutation accounting for the majority). Amongst the numerous genetic mutations, prior research has linked PTPN11 gene mutations to hypertrophic cardiomyopathy. Our case sheds light on the association between PTPN11 mutation and the development of isolated DCM. Case A 54-year-old lady with no remarkable medical history presented with typical symptoms of heart failure. CT coronary angiography revealed normal coronary arteries, and echocardiography (fig.1) demonstrated a left ventricular ejection fraction of 40%, with an indexed left ventricular end-diastolic volume (LVEDVi) of 79 ml/m2, suggestive of moderate-severe dilation. The patient also had a family history of non-ischemic heart failure with reduced ejection fraction (HFrEF) in her younger sister at the age of 45, reportedly due to stress but with no extensive workup. Stemming from the patient's refusal to undergo cardiac MRI, genetic testing was pursued, and she underwent whole genome testing which identified a missense mutation in coding exon 7 of the PTPN11 gene. Discussion PTPN11 is a gene that produces SHP2, a tyrosine phosphatase (PTP) protein. A gain of function mutation in PTPN11 is responsible for approximately 50% of cases of Noonan syndrome (NS). Although NS is commonly associated with hypertrophic cardiomyopathy (HCM) that leads to heart failure with preserved ejection fraction (HFpEF), the prevalence of HCM is low in individuals with NS caused by PTPN11 mutation. Conversely, DCM, which leads to HFrEF, has been rarely reported in NS, with only two documented cases in literature, albeit correlation with PTPN11 was not specified. Murine studies suggested that a deletion mutation in PTPN11 leads to abnormal activation of the Erk/MAPK protein and RhoA signaling pathways, resulting in rapid DCM development. Additionally, missense defects in PTPN11 were found to lead to prolonged phosphatase activity, mutations of which (mainly PP1 and PP2A, reportedly present in human hearts) also lead to DCM. Our patient was found to carry a specific PTPN11 mutation: c.794G>T(p.Arg265Leu), which is inherited in an autosomal dominant manner. Given that she had no predisposing factors for DCM, it is speculated that this PTPN11 variant may be an independent risk factor for isolated DCM induced HFrEF. Further clinical correlation and familial testing are required to fully understand the effect of this variant on the heart, which could have significant implications for both diagnosis and treatment of this debilitating cardiovascular disorder.

PTPN11 Mutation, A Heartbreaking Revelation

The Novel Mitochondrial 16S Rrna 2336T>C Mutation is Associated with Hypertrophic Cardiomyopathy

Association Between SCN5A R225Q Variant and Dilated Cardiomyopathy: Potential Role of Intracellular Ph and WNT/β-catenin Pathway

PTPN11 Gene Mutations and Its Association with the Risk of Congenital Heart Disease

Identification of novel TTN gene variant in a patient exhibiting severe dilated cardiomyopathy co-occurring with acute fibrinoid organizing pneumonia

The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia

Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient Ipsc-Derived Cardiomyocytes with MT-RNR2 Mutation.

Genetic variations in PTPN11 lead to a recurrent Left Ventricular Outflow Tract Obstruction phenotype in childhood hypertrophic cardiomyopathy

Case Report: A New De Novo Mutation of the Troponin T2 Gene in a Chinese Patient with Dilated Cardiomyopathy

A Novel Mutation in the Tropomyosin 1 Gene in a Chinese Patient with Hypertrophic Cardiomyopathy

A Harmful MYH11 Variant Detected in a Family with Thoracic Aortic Dissection and Patent Ductus Arteriosus.

A Novel Nkx2-5 Loss-Of-Function Mutation Predisposes to Familial Dilated Cardiomyopathy and Arrhythmias

Functional Consequences of A Novel Cardiac Troponin T Mutation Linked to Infantile Restrictive Cardiomyopathy

Case Report: Mutation in TNNI3(c. 544G>A): a novel likely pathogenic mechanism of neonatal dilated cardiomyopathy

Homozygous TNNI3 frameshift variant in a consanguineous family with lethal infantile dilated cardiomyopathy

Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort

Identification of a Novel Variant in N-cadherin Associated with Dilated Cardiomyopathy.

A Novel GATA4 Loss-of-function Mutation Responsible for Familial Dilated Cardiomyopathy

Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy

A Novel Arginine to Tryptophan (R144W) Mutation in Troponin T (cTnT) Gene in an Indian Multigenerational Family with Dilated Cardiomyopathy (FDCM)

A Novel Tbx20 Loss-Of-Function Mutation Contributes to Adult-Onset Dilated Cardiomyopathy or Congenital Atrial Septal Defect